Skip to main content
Top
Published in: Gastric Cancer 3/2019

01-05-2019 | Original Article

CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial

Authors: Jun Lu, Bin-bin Xu, Zhi-fang Zheng, Jian-wei Xie, Jia-bin Wang, Jian-xian Lin, Qi-yue Chen, Long-long Cao, Mi Lin, Ru-hong Tu, Ze-ning Huang, Chao-hui Zheng, Chang-Ming Huang, Ping Li

Published in: Gastric Cancer | Issue 3/2019

Login to get access

Abstract

Background

Serum prealbumin (PALB) can predict the prognosis of patients with gastric cancer (GC). However, the prognostic value of combination of C-reactive protein and PALB (CRP/PALB) remains unclear.

Methods

A total of 419 gastric cancer patients included in a clinical trial (NCT02327481) were analyzed. The present study is a substudy of the trial. Receiver operating characteristic (ROC) curves were generated, and by calculating the areas under the curve (AUC) and the C-index, the discriminative ability of each inflammatory index was compared, including CRP/PALB, C-reactive protein/albumin, Glasgow prognostic score (GPS), modified GPS, systemic immune-inflammation index, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio.

Results

Ultimately, 401 patients were included in this study. The optimal cutoff value of CRP/PALB was 17.7. According to this cutoff point, the entire sample was divided into a CRP/PALB < 17.7 (LCP) group and a CRP/PALB ≥ 17.7 (HCP) group, comprising 245 and 156 patients, respectively. There were 54 and 22 patients experienced recurrence in the HCP and LCP group, respectively, p < 0.001. Compared with traditional inflammatory indices, CRP/PALB had the highest AUC (0.707) and C-index (0.716), all p < 0.05. The post-recurrence survival (PRS) of patients in the HCP group was significantly shorter than that in the LCP group (p = 0.010), especially for pathological stage III patients (p = 0.015) or patients with distant (p = 0.018) or local (p = 0.023) recurrences.

Conclusions

The predictive value of preoperative CRP/PALB for the recurrence of GC is significantly better than traditional inflammatory indices. HCP significantly reduces the PRS, especially for pathological stage III patients or patients with distant or local recurrences.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40(3):250–60.CrossRefPubMed Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40(3):250–60.CrossRefPubMed
2.
go back to reference Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45.CrossRefPubMed Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45.CrossRefPubMed
3.
go back to reference Miyamoto R, Inagawa S, Sano N, et al. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur J Surg Oncol. 2018;44(5):607–12.CrossRefPubMed Miyamoto R, Inagawa S, Sano N, et al. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur J Surg Oncol. 2018;44(5):607–12.CrossRefPubMed
4.
5.
go back to reference Chen XD, Mao CC, Wu RS, et al. Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer. PLoS One. 2017;12(4):e0175074.CrossRefPubMedPubMedCentral Chen XD, Mao CC, Wu RS, et al. Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer. PLoS One. 2017;12(4):e0175074.CrossRefPubMedPubMedCentral
6.
go back to reference Liu X, Sun X, Liu J, et al. Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Transl Oncol. 2015;8(4):339–45.CrossRefPubMedPubMedCentral Liu X, Sun X, Liu J, et al. Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Transl Oncol. 2015;8(4):339–45.CrossRefPubMedPubMedCentral
7.
go back to reference Gonda K, Shibata M, Sato Y, et al. Elevated neutrophil-to-lymphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S-1 plus cisplatin, and poor prognosis in patients with stage IV gastric cancer. Mol Clin Oncol. 2017;7(6):1073–8.PubMedPubMedCentral Gonda K, Shibata M, Sato Y, et al. Elevated neutrophil-to-lymphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S-1 plus cisplatin, and poor prognosis in patients with stage IV gastric cancer. Mol Clin Oncol. 2017;7(6):1073–8.PubMedPubMedCentral
8.
go back to reference Unal D, Orhan O, Eroglu C, et al. Prealbumin is a more sensitive marker than albumin to assess the nutritional status in patients undergoing radiotherapy for head and neck cancer. Contemp Oncol (Pozn). 2013;17(3):276–80. Unal D, Orhan O, Eroglu C, et al. Prealbumin is a more sensitive marker than albumin to assess the nutritional status in patients undergoing radiotherapy for head and neck cancer. Contemp Oncol (Pozn). 2013;17(3):276–80.
9.
go back to reference Wang J, Zhao J, Zhang Y, et al. Early enteral nutrition and total parenteral nutrition on the nutritional status and blood glucose in patients with gastric cancer complicated with diabetes mellitus after radical gastrectomy. Exp Ther Med. 2018;16(1):321–7.PubMedPubMedCentral Wang J, Zhao J, Zhang Y, et al. Early enteral nutrition and total parenteral nutrition on the nutritional status and blood glucose in patients with gastric cancer complicated with diabetes mellitus after radical gastrectomy. Exp Ther Med. 2018;16(1):321–7.PubMedPubMedCentral
10.
go back to reference Nikniaz Z, Somi MH, Nagashi S, et al. Impact of early enteral nutrition on nutritional and immunological outcomes of gastric cancer patients undergoing gastrostomy: a systematic review and meta-analysis. Nutr Cancer. 2017;69(5):693–701.CrossRefPubMed Nikniaz Z, Somi MH, Nagashi S, et al. Impact of early enteral nutrition on nutritional and immunological outcomes of gastric cancer patients undergoing gastrostomy: a systematic review and meta-analysis. Nutr Cancer. 2017;69(5):693–701.CrossRefPubMed
11.
go back to reference Shimura T, Shibata M, Gonda K, et al. Serum transthyretin level is associated with prognosis of patients with gastric cancer. J Surg Res. 2018;227:145–50.CrossRefPubMed Shimura T, Shibata M, Gonda K, et al. Serum transthyretin level is associated with prognosis of patients with gastric cancer. J Surg Res. 2018;227:145–50.CrossRefPubMed
12.
go back to reference Zhou H, Jiang X, Li Q, et al. A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma. Am J Cancer Res. 2015;5(5):1831–43.PubMedPubMedCentral Zhou H, Jiang X, Li Q, et al. A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma. Am J Cancer Res. 2015;5(5):1831–43.PubMedPubMedCentral
13.
go back to reference Kawai H, Ota H. Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg. 2012;36(12):2853–7.CrossRefPubMed Kawai H, Ota H. Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg. 2012;36(12):2853–7.CrossRefPubMed
14.
go back to reference Han WX, Chen ZM, Wei ZJ, et al. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction. World J Surg Oncol. 2016;14(1):279.CrossRefPubMedPubMedCentral Han WX, Chen ZM, Wei ZJ, et al. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction. World J Surg Oncol. 2016;14(1):279.CrossRefPubMedPubMedCentral
15.
go back to reference Zheng CH, Lu J, Zheng HL, et al. Comparison of 3D laparoscopic gastrectomy with a 2D procedure for gastric cancer: a phase 3 randomized controlled trial. Surgery. 2018;163(2):300–4.CrossRefPubMed Zheng CH, Lu J, Zheng HL, et al. Comparison of 3D laparoscopic gastrectomy with a 2D procedure for gastric cancer: a phase 3 randomized controlled trial. Surgery. 2018;163(2):300–4.CrossRefPubMed
16.
go back to reference Lu J, Zheng CH, Zheng HL, et al. Randomized, controlled trial comparing clinical outcomes of 3D and 2D laparoscopic surgery for gastric cancer: an interim report. Surg Endosc. 2017;31(7):2939–45.CrossRefPubMed Lu J, Zheng CH, Zheng HL, et al. Randomized, controlled trial comparing clinical outcomes of 3D and 2D laparoscopic surgery for gastric cancer: an interim report. Surg Endosc. 2017;31(7):2939–45.CrossRefPubMed
17.
go back to reference Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077–9.CrossRef Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077–9.CrossRef
18.
go back to reference McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–40.CrossRefPubMed McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–40.CrossRefPubMed
19.
go back to reference Park JH, Watt DG, Roxburgh CS, et al. Colorectal cancer, systemic inflammation, and outcome: staging the tumor and staging the host. Ann Surg. 2016;263(2):326–36.CrossRefPubMed Park JH, Watt DG, Roxburgh CS, et al. Colorectal cancer, systemic inflammation, and outcome: staging the tumor and staging the host. Ann Surg. 2016;263(2):326–36.CrossRefPubMed
20.
go back to reference Lee D, Son SY, Kim YB, et al. Neural invasion is a significant contributor to peritoneal recurrence in signet ring cell gastric carcinoma. Ann Surg Oncol. 2018;25:1167–1175CrossRefPubMed Lee D, Son SY, Kim YB, et al. Neural invasion is a significant contributor to peritoneal recurrence in signet ring cell gastric carcinoma. Ann Surg Oncol. 2018;25:1167–1175CrossRefPubMed
21.
go back to reference Jin LX, Moses LE, Squires MH III. Factors associated with recurrence and survival in lymph node-negative gastric adenocarcinoma: A 7-institution study of the US Gastric Cancer Collaborative. Ann Surg. 2015;262(6):999–1005. rd, et al.CrossRefPubMed Jin LX, Moses LE, Squires MH III. Factors associated with recurrence and survival in lymph node-negative gastric adenocarcinoma: A 7-institution study of the US Gastric Cancer Collaborative. Ann Surg. 2015;262(6):999–1005. rd, et al.CrossRefPubMed
22.
go back to reference Bantis LE, Nakas CT, Reiser B. Construction of confidence regions in the ROC space after the estimation of the optimal Youden index-based cut-off point. Biometrics. 2014;70(1):212–23.CrossRefPubMed Bantis LE, Nakas CT, Reiser B. Construction of confidence regions in the ROC space after the estimation of the optimal Youden index-based cut-off point. Biometrics. 2014;70(1):212–23.CrossRefPubMed
23.
go back to reference Heagerty P, Lumley T, Pepe M. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–44.CrossRefPubMed Heagerty P, Lumley T, Pepe M. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–44.CrossRefPubMed
24.
go back to reference Alifano M, Mansuet-Lupo A, Lococo F, et al. Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer. PLoS One. 2014;9(9):e106914.CrossRefPubMedPubMedCentral Alifano M, Mansuet-Lupo A, Lococo F, et al. Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer. PLoS One. 2014;9(9):e106914.CrossRefPubMedPubMedCentral
25.
go back to reference Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454(7203):436–44.CrossRef Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454(7203):436–44.CrossRef
26.
go back to reference Fankhauser CD, Sander S, Roth L, et al. Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. Br J Cancer. 2018;118(6):825–30.CrossRefPubMedPubMedCentral Fankhauser CD, Sander S, Roth L, et al. Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. Br J Cancer. 2018;118(6):825–30.CrossRefPubMedPubMedCentral
27.
go back to reference Thibodeau J, Bourgeois-Daigneault MC, Lapointe R. Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy. Oncoimmunology. 2012;1(6):908–16.CrossRefPubMedPubMedCentral Thibodeau J, Bourgeois-Daigneault MC, Lapointe R. Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy. Oncoimmunology. 2012;1(6):908–16.CrossRefPubMedPubMedCentral
28.
go back to reference Liu Z, Jin K, Guo M, et al. Prognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancer. Ann Surg Oncol. 2017;24(2):561–8.CrossRefPubMed Liu Z, Jin K, Guo M, et al. Prognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancer. Ann Surg Oncol. 2017;24(2):561–8.CrossRefPubMed
29.
go back to reference Mano Y, Shirabe K, Yamashita Y, et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013;258(2):301–5.CrossRefPubMed Mano Y, Shirabe K, Yamashita Y, et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013;258(2):301–5.CrossRefPubMed
31.
go back to reference Shimada H, Takiguchi N, Kainuma O, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer. 2010;13(3):170–6.CrossRef Shimada H, Takiguchi N, Kainuma O, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer. 2010;13(3):170–6.CrossRef
32.
go back to reference Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–54.CrossRef Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–54.CrossRef
33.
go back to reference Ilhan N, Ilhan N, Ilhan Y, et al. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol. 2004;10(8):1115–20.CrossRefPubMedPubMedCentral Ilhan N, Ilhan N, Ilhan Y, et al. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol. 2004;10(8):1115–20.CrossRefPubMedPubMedCentral
34.
go back to reference Sansone P, Storci G, Tavolari S, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007;117(12):3988–4002.CrossRefPubMedPubMedCentral Sansone P, Storci G, Tavolari S, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007;117(12):3988–4002.CrossRefPubMedPubMedCentral
35.
go back to reference Grimm T, Buchner A, Schneevoigt B, et al. Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study. World J Urol. 2016;34(5):703–8.CrossRefPubMed Grimm T, Buchner A, Schneevoigt B, et al. Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study. World J Urol. 2016;34(5):703–8.CrossRefPubMed
36.
go back to reference Basu S, Harris H, Larsson A, et al. Is there any role for serum cathepsin S and CRP levels on prognostic information in breast cancer? The Swedish Mammography Cohort. Antioxid Redox Signal. 2015;23(16):1298–302.CrossRefPubMed Basu S, Harris H, Larsson A, et al. Is there any role for serum cathepsin S and CRP levels on prognostic information in breast cancer? The Swedish Mammography Cohort. Antioxid Redox Signal. 2015;23(16):1298–302.CrossRefPubMed
37.
go back to reference Miura K, Hamanaka K, Koizumi T, et al. Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: Comparative study of normal lung, emphysema, and pulmonary fibrosis. Lung Cancer. 2017;111:88–95.CrossRefPubMed Miura K, Hamanaka K, Koizumi T, et al. Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: Comparative study of normal lung, emphysema, and pulmonary fibrosis. Lung Cancer. 2017;111:88–95.CrossRefPubMed
38.
go back to reference Ishino Y, Saigusa S, Ohi M, et al. Preoperative C-reactive protein and operative blood loss predict poor prognosis in patients with gastric cancer after laparoscopy-assisted gastrectomy. Asian J Endosc Surg. 2014;7(4):287–94.CrossRef Ishino Y, Saigusa S, Ohi M, et al. Preoperative C-reactive protein and operative blood loss predict poor prognosis in patients with gastric cancer after laparoscopy-assisted gastrectomy. Asian J Endosc Surg. 2014;7(4):287–94.CrossRef
39.
go back to reference Takamori S, Toyokawa G, Shimokawa M, et al. The C-reactive protein/albumin ratio is a novel significant prognostic factor in patients with malignant pleural mesothelioma: a retrospective multi-institutional study. Ann Surg Oncol. 2018;25(6):1555–63.CrossRefPubMed Takamori S, Toyokawa G, Shimokawa M, et al. The C-reactive protein/albumin ratio is a novel significant prognostic factor in patients with malignant pleural mesothelioma: a retrospective multi-institutional study. Ann Surg Oncol. 2018;25(6):1555–63.CrossRefPubMed
40.
go back to reference Saito H, Kono Y, Murakami Y, et al. Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil–lymphocyte ratio in gastric cancer patients. World J Surg. 2018;42(6):1819–25.CrossRef Saito H, Kono Y, Murakami Y, et al. Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil–lymphocyte ratio in gastric cancer patients. World J Surg. 2018;42(6):1819–25.CrossRef
41.
42.
go back to reference Chertow GM, Ackert K, Lew NL, et al. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. Kidney Int. 2000;58(6):2512–7.CrossRefPubMed Chertow GM, Ackert K, Lew NL, et al. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. Kidney Int. 2000;58(6):2512–7.CrossRefPubMed
43.
go back to reference Myron Johnson A, Merlini G, Sheldon J, et al. Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition. Clin Chem Lab Med. 2007;45(3):419–26.CrossRef Myron Johnson A, Merlini G, Sheldon J, et al. Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition. Clin Chem Lab Med. 2007;45(3):419–26.CrossRef
44.
go back to reference Zhu HF, Li J, Huang L, et al. Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases. Hepatogastroenterology. 2013;60(122):263–7.PubMed Zhu HF, Li J, Huang L, et al. Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases. Hepatogastroenterology. 2013;60(122):263–7.PubMed
45.
go back to reference Galizia G, Lieto E, Zamboli A, et al. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis. Surgery. 2015;158(1):112–20.CrossRefPubMed Galizia G, Lieto E, Zamboli A, et al. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis. Surgery. 2015;158(1):112–20.CrossRefPubMed
47.
go back to reference Powell A, Parkinson D, Patel N, et al. Prognostic significance of serum inflammatory markers in gastric cancer. J Gastrointest Surg. 2018;22(4):595–605.CrossRefPubMed Powell A, Parkinson D, Patel N, et al. Prognostic significance of serum inflammatory markers in gastric cancer. J Gastrointest Surg. 2018;22(4):595–605.CrossRefPubMed
48.
go back to reference Mohri Y, Tanaka K, Ohi M, et al. Inflammation-based prognostic score as a predictor of postoperative gastric cancer recurrence. Anticancer Res. 2012;32(10):4581–4.PubMed Mohri Y, Tanaka K, Ohi M, et al. Inflammation-based prognostic score as a predictor of postoperative gastric cancer recurrence. Anticancer Res. 2012;32(10):4581–4.PubMed
49.
go back to reference Lee JH, Chang KK, Yoon C, et al. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018;267(1):105–13.CrossRefPubMedPubMedCentral Lee JH, Chang KK, Yoon C, et al. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018;267(1):105–13.CrossRefPubMedPubMedCentral
Metadata
Title
CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial
Authors
Jun Lu
Bin-bin Xu
Zhi-fang Zheng
Jian-wei Xie
Jia-bin Wang
Jian-xian Lin
Qi-yue Chen
Long-long Cao
Mi Lin
Ru-hong Tu
Ze-ning Huang
Chao-hui Zheng
Chang-Ming Huang
Ping Li
Publication date
01-05-2019
Publisher
Springer Singapore
Published in
Gastric Cancer / Issue 3/2019
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-018-0892-0

Other articles of this Issue 3/2019

Gastric Cancer 3/2019 Go to the issue